Apple Inc. will launch two new apps that will give some iPhone users the opportunity to provide their DNA samples for medical research. This will make Apple another American IT company involved in genetic research.
Apple Inc. will launch two new apps that will give some iPhone users the opportunity to provide their DNA samples for medical research. This will make Apple another American IT company involved in genetic research.
The two new apps will run on Apple's ResearchKit software platform released in March this year. The platform is designed to help medical researchers collect research data from Apple's iPhone, helping to solve the problems that medical researchers face when recruiting volunteers as research subjects.
The MIT Technology Review said on the 5th that Apple is working with the University of California at San Francisco and Mount Sinai Hospital in New York to launch two applications that will help DNA research. The researchers recruited volunteers through the two applications and agreed to participate in the study of iPhone users to provide their DNA samples to research institutions. Apple is not directly involved in collecting or testing DNA samples. The iPhone will be a tool for communication between volunteers and researchers.
The two institutions plan to study about 100 medically important disease genes. Like several previously released applications on the ResearchKit platform, the two research projects will require approval from Apple and a review board for volunteers.
Apple is likely to release the two apps at the developer conference in June this year.
As gene therapy becomes a hot trend in medical research, some US IT companies are interested in building large genetic information databases and participating in genetic research in different ways. For example, Google Inc. launched a genetic data cloud computing service that hopes to store as much genetic data as possible for researchers to use. There are also direct-to-consumer companies that use mobile devices and apps to collect personal genetic information.
Http://news.chinawj.com.cn Editor: (Hardware Business Network Information Center) http://news.chinawj.com.cn
InVent PS 10 – a series of Monodisperse Reversed Phased Polymeric Resin designed for the polishing purification and separation for pharmaceuticals and natural products. These resins are made from highly cross-linked polymers of styrene and divinylbenzen, has an excellent pH stability over a wide range of pH 1-14; especially shows outstanding stability in extremely acidicor alkaline solutions (such as 1mol/L HCl\NaOH) and organic solvents ( such as methanol, ethanol, acetone, n-propanol, isopropanol, DMSO, THF, acetonitrile, 6 M guanidine hydrochloride, etc.)
By the benefits of its good performance and superior chemical and pH stability, InVent PS 10 is widely used in the high-class drink, purification for pharmaceuticals and so on.
10 Micron Monodisperse Resin Invent
10 Micron Monodisperse Resin Invent,Core Shell Structure Resin,Resin Of Reversed Phase Polymeric,10 Micron Monodisperse Resin
Nanjing Genshine Bio-technology Co., Ltd , http://www.genshine-bio.com